Financials
- Market Capitalization 4.11 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-41.64
市销率
8.9
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1390 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 79.29 USD | -2.80% | -8.67% | -26.83% | +129.16% | 4.44 B USD | ||
| 1436 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 37.44 USD | -2.63% | -7.99% | -14.87% | +145.83% | 4.07 B USD | ||
| 1473 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.26 USD | -3.76% | +4.49% | -3.00% | +177.90% | 3.92 B USD | ||
| 1477 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.83 USD | -0.83% | -6.06% | -5.91% | +191.34% | 3.91 B USD |